Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) shares fell 6.4% during mid-day trading on Tuesday . The stock traded as low as $0.65 and last traded at $0.65. 125 shares changed hands during trading, a decline of 95% from the average session volume of 2,362 shares. The stock had previously closed at $0.69.
Avacta Group Price Performance
The stock’s 50 day moving average is $0.62 and its two-hundred day moving average is $0.77.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Further Reading
- Five stocks we like better than Avacta Group
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Election Stocks: How Elections Affect the Stock Market
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
